This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Diffusion Pharmaceuticals Crecimiento futuro
Future controles de criterios 0/6
Información clave
21.4%
Tasa de crecimiento de los beneficios
41.9%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 30.8% |
| Tasa de crecimiento de los ingresos | 66.5% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 3 | -15 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -18 | N/A | N/A | 2 |
| 12/31/2023 | N/A | -17 | N/A | N/A | 2 |
| 12/31/2022 | N/A | -16 | N/A | N/A | 2 |
| 9/30/2022 | N/A | -15 | -15 | -15 | N/A |
| 6/30/2022 | N/A | -24 | -15 | -15 | N/A |
| 3/31/2022 | N/A | -24 | -14 | -14 | N/A |
| 12/31/2021 | N/A | -24 | -15 | -15 | N/A |
| 9/30/2021 | N/A | -25 | -15 | -15 | N/A |
| 6/30/2021 | N/A | -17 | -15 | -15 | N/A |
| 3/31/2021 | N/A | -18 | -15 | -15 | N/A |
| 12/31/2020 | N/A | -16 | -14 | -14 | N/A |
| 9/30/2020 | N/A | -16 | -13 | -13 | N/A |
| 6/30/2020 | N/A | -14 | -11 | -11 | N/A |
| 3/31/2020 | N/A | -12 | -11 | -11 | N/A |
| 12/31/2019 | N/A | -12 | -10 | -10 | N/A |
| 9/30/2019 | N/A | -14 | -10 | -10 | N/A |
| 6/30/2019 | N/A | -18 | -10 | -10 | N/A |
| 3/31/2019 | N/A | -18 | -10 | -10 | N/A |
| 12/31/2018 | N/A | -27 | -11 | -11 | N/A |
| 9/30/2018 | N/A | -20 | -10 | -10 | N/A |
| 6/30/2018 | N/A | -10 | -12 | -12 | N/A |
| 3/31/2018 | N/A | 4 | -13 | -12 | N/A |
| 12/31/2017 | N/A | -3 | -13 | -12 | N/A |
| 9/30/2017 | N/A | -7 | -12 | -11 | N/A |
| 6/30/2017 | N/A | -15 | -10 | -9 | N/A |
| 3/31/2017 | N/A | -30 | -10 | -10 | N/A |
| 12/31/2016 | N/A | -18 | -11 | -11 | N/A |
| 9/30/2016 | N/A | -18 | -12 | -12 | N/A |
| 6/30/2016 | N/A | -14 | N/A | -11 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: DP81 is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: DP81 is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: DP81 is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: DP81 is forecast to have no revenue next year.
Ingresos de alto crecimiento: DP81 is forecast to have no revenue next year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if DP81's Return on Equity is forecast to be high in 3 years time